Ablation for ICD Intervention Reduction in Patients With CAD
ABLATION 4 ICD
1 other identifier
interventional
200
1 country
1
Brief Summary
The aim of this study is to assess the role of ablation in appropriate ICD interventions reduction in patients with coronary artery disease. The group will consist of 200 patients with implanted ICD and appropriate intervention in the 3 months prior to enrollment. The patients will be randomized into ablation arm and conventional treatment. Number of appropriate ICD interventions is the primary endpoint of this study. All patients will have control follow-up visits every 3 months. The follow-up will be based on ICD memory.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2007
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2007
CompletedFirst Submitted
Initial submission to the registry
May 30, 2007
CompletedFirst Posted
Study publicly available on registry
June 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2010
CompletedJuly 21, 2008
July 1, 2008
May 30, 2007
July 18, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of appropriate ICD interventions
Secondary Outcomes (4)
Overall mortality
Cardiac mortality
Hospitalization due to arrhythmia or heart failure
Quality of life
Interventions
Eligibility Criteria
You may qualify if:
- Coronary Artery Disease
- ICD implanted
- Appropriate ICD intervention during the 3 months prior to enrollment
- Coronary angiography during the 6 months prior to enrollment
- Possible revascularization
- Age over 18 years
- Signed informed consent
You may not qualify if:
- Age less then 18 years
- Pregnancy
- Active participation in other trial
- Heart failure (NYHA IV)
- Contraindications for ablation procedure: i.e. left ventricular thrombus, artificial aortic or mitral valve, no vascular access.
- Monomorphic, incessant, ventricular tachycardia
- Revascularization or other cardio-surgical procedure scheduled in the next 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute of Cardiology
Warsaw, Masovian Voivodeship, 04-628, Poland
Related Publications (1)
Szumowski L, Przybylski A, Maciag A, Derejko P, Bodalski R, Zakrzewska J, Orczykowski M, Szufladowicz E, Szwed H, Walczak F. Outcomes of a single centre registry of patients with ischaemic heart disease, qualified for an RF ablation of ventricular arrhythmia after ICD intervention. Kardiol Pol. 2009 Feb;67(2):123-7; discussion 128-9. English, Polish.
PMID: 19288374DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lukasz J Szumowski, MD, PhD
National Institute of Cardiology, Warsaw, Poland
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
May 30, 2007
First Posted
June 1, 2007
Study Start
May 1, 2007
Study Completion
May 1, 2010
Last Updated
July 21, 2008
Record last verified: 2008-07